tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AC Immune announces publication of results on ACI-35.030 in eBioMedicine
The FlyAC Immune announces publication of results on ACI-35.030 in eBioMedicine
4d ago
JNJ
ACIU
AC Immune SA: Strategic Focus and Innovative Platforms Drive Buy Rating Amid Promising Immunotherapy Developments
PremiumRatings
AC Immune SA: Strategic Focus and Innovative Platforms Drive Buy Rating Amid Promising Immunotherapy Developments
21d ago
ACIU
AC Immune SA Announces Strategic Focus and Workforce Reduction
PremiumCompany Announcements
AC Immune SA Announces Strategic Focus and Workforce Reduction
25d ago
6K
ACIU
AC Immune Reports Q2 2025 Financial Progress
PremiumCompany Announcements
AC Immune Reports Q2 2025 Financial Progress
2M ago
ACIU
AC Immune SA: Promising Pipeline and Strong Financial Position Justify Buy Rating
PremiumRatings
AC Immune SA: Promising Pipeline and Strong Financial Position Justify Buy Rating
2M ago
ACIU
AC Immune SA Reports Increased Losses in Mid-2025 Financial Results
PremiumCompany AnnouncementsAC Immune SA Reports Increased Losses in Mid-2025 Financial Results
2M ago
6K
ACIU
AC Immune reports Q2 EPS (CHF 0.21) vs. (CHF 0.23) last year
Premium
The Fly
AC Immune reports Q2 EPS (CHF 0.21) vs. (CHF 0.23) last year
2M ago
ACIU
AC Immune sees cash runway into 1Q27
Premium
The Fly
AC Immune sees cash runway into 1Q27
2M ago
ACIU
AC Immune SA Announces AGM Results and Strategic Approvals
PremiumCompany Announcements
AC Immune SA Announces AGM Results and Strategic Approvals
3M ago
6K
ACIU
AC Immune SA Announces Leadership Changes in Development Team
PremiumCompany Announcements
AC Immune SA Announces Leadership Changes in Development Team
4M ago
6K
ACIU
AC Immune SA Announces Board Changes Ahead of June 2025 AGM
PremiumCompany Announcements
AC Immune SA Announces Board Changes Ahead of June 2025 AGM
4M ago
6K
ACIU
AC Immune’s Promising Pipeline and Strong Financial Position Justify Buy Rating
PremiumRatings
AC Immune’s Promising Pipeline and Strong Financial Position Justify Buy Rating
5M ago
ACIU
AC Immune price target lowered to $12 from $16 at H.C. Wainwright
PremiumThe FlyAC Immune price target lowered to $12 from $16 at H.C. Wainwright
5M ago
ACIU
AC Immune Reports Q1 2025 Financial Results
Premium
Company Announcements
AC Immune Reports Q1 2025 Financial Results
5M ago
6K
ACIU
AC Immune reports Q1 EPS (19c) vs (18c) last year
Premium
The Fly
AC Immune reports Q1 EPS (19c) vs (18c) last year
5M ago
ACIU
ACIU Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ACIU Earnings this Week: How Will it Perform?
5M ago
ACIU
AC Immune SA: Promising Phase 2 Results and Positive Outlook Drive Buy Rating
PremiumRatings
AC Immune SA: Promising Phase 2 Results and Positive Outlook Drive Buy Rating
6M ago
ACIU
AC Immune’s Strategic Advances and Financial Highlights
PremiumCompany Announcements
AC Immune’s Strategic Advances and Financial Highlights
6M ago
ACIU
AC Immune announces additional data from Phase 2 study of VacSYn clinical trial
PremiumThe Fly
AC Immune announces additional data from Phase 2 study of VacSYn clinical trial
6M ago
ACIU
Promising Developments in AC Immune SA’s ACI-7104 Program Drive Buy Rating
PremiumRatingsPromising Developments in AC Immune SA’s ACI-7104 Program Drive Buy Rating
7M ago
ACIU
AC Immune: Promising Pipeline and Financial Stability Drive Buy Rating
Premium
Ratings
AC Immune: Promising Pipeline and Financial Stability Drive Buy Rating
7M ago
ACIU
AC Immune SA Reports 2024 Financial Results and Strategic Advances
Premium
Company Announcements
AC Immune SA Reports 2024 Financial Results and Strategic Advances
7M ago
6K
ACIU

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >